BioTech Firm Wants Redo In $7.5M IP Fight At Fed Circ.
Biotechnology company Novozymes A/S has told the Federal Circuit it can't be liable for infringing ethanol processing patents because a previous invention clearly anticipated the patented technology, and it asked the...To view the full article, register now.
Already a subscriber? Click here to view full article